The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 1176-1180

  Bulotta, Angela ^a   Ludovico, Ornella ^a   Coco, Angelo ^a   Di Paola, Rosa ^a   Quattrone, Alessandro ^a   Carella, Massimo ^a   Pellegrini, Fabio ^b   Prudente, Sabrina ^c   Trischitta, Vincenzo ^a,c,d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c Casa Sollievo Sofferenza M Inst   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADULT; AGED; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN RELEASE; ITALY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; ADULT; AGED; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GUANINE; HUMANS; ION CHANNELS; ITALY; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 14044254272     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1072     Document Type: Article

References (31)

1. King H, Aubert RE, Herman WH 1998 Global burden of diabetes 1995-2025. Diabetes Care 21:1414-1431
2. Kahn SE 2003 The relative contribution of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
3. Almind K, Doria A, Kahn CR 2001 Putting the genes for type II diabetes on the map. Nat Med 3:277-279
4. O'Railly S 2001 Uncoupling protein 2: adiposity angel and diabetes devil? Nat Med 7:770-772
5. Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB 1999 Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48:1482-1486
6. Zhang CY, Baffy G, Perret G, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng X, Wheeler MB, Shulman GI, Chan CB, Lowell BB 2001 Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell 105:745-755
7. Wang MY, Shimabukuro M, Lee Y, Trinh KY, Chen JL, Newgard CB, Unger RH 1999 1999 Adenovirus-mediated overexpression of uncoupling protein-2 in pancreatic islets of Zucker diabetic rats increases oxidative activity and improves β-cell function. Diabetes 48:1020-1025
8. Kaisaki PJ, Woon PY, Wallis RH, Monaco AP, Lathrop M, Gauguier D 1998 Localization of tub and uncoupling proteins (Ucp) 2 and 3 to a region of rat chromosome 1 linked to glucose intolerance and adiposity in the Goto-Kakizaki (Gk) type 2 diabetic rat. Mamm Genome 9:910-912
9. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamäki K, Chines P, Balow Jr J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschack-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M 2000 The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) study I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67:1174-1185
10. Dalgaard LT, Pedersen O 2001 Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type 2 diabetes. Diabetologia 44:946-965
11. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W 2001 A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178-183
12. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, Xie M, Linnemayr V, Oberkofler H, Patsch W 2002 A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 51:3331-3335
13. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC 2004 Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol 286:E1-E7
14. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, Lauro D, De Nicolais P, Sbraccia P, Del Prato S, Gambardella S, Federici M, Marchetti P, Lauro R 2003 A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 52:1280-1283
15. 12 Ala polymorphism. Diabetes 51:2341-2347
16. 12 Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
17. Masugi J, Tamori Y, Mori H, Koike T, Kasuga M 2000 Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator activated receptor-γ2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 268:178-182
18. 12 Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
19. Shimabukuro M, Zhou YT, Lee Y, Unger RH 1997 Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats. Biochem Biophys Res Commun 237:359-361
20. Patane' G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM 2002 Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes 51:2749-2756
21. Shimabukuro M, Zhou YT, Lee Y, Unger RH 1998 Troglitazone lowers islet fat and restores β cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547-3550
22. Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC, Clapham JC 1998 Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47:1326-1334
23. Lupi R, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, Del Prato S 2004 Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR72 in the modulation of insulin secretion. Am J Physiol 286:E560-E567
24. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, Soccio T, Mastroianno S, Tassi V, Almgren P, Pizzuti A, Vigneri R, Trischitta V 2002 A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-812
25. Baratta R, Di Paola R, Spampinato D, Fini G, Marucci A, Coco A, Vigneri R, Frittitta L, Trischitta V 2003 Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARγ2 (P12A) polymorphisms. J Mol Med 81:718-723
26. Efron B, Tibshirani RJ 1993 An introduction to the bootstrap, chapt 15. New York: Chapman, Hall; 202-218
27. Schneider S, Roessli D, Excoffier L 2000 Arlequin: a software for population genetics data analysis, version 2.000. Geneva: University of Geneva
28. Tu N, Chen H, Winnikes U, Reinert I, Marmann G, Pirke KM, Lentes KU 1999 Molecular cloning and functional characterization of the promoter region of the human uncoupling protein-2 gene. Biochem Biophys Res Commun 265:326-334
29. Cho YM, Ritchie MD, Moore JH, Park JY, Lee KU, Shin HD, Lee HK, Park KS 2004 Multifactor-dimensionality reduction shows a two-locus interaction associated with type 2 diabetes mellitus. Diabetologia 47:549-554
30. Lander ES, Schork NJ 1994 Genetic dissection of complex traits. Science 265:2037-2048
31. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Pattereon N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MP, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D 2004 Assessing the impact of population stratification on genetic association study. Nat Genet 36:388-393